HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Pei Lin Selected Research
Pei Lin Research Topics
Disease
42
Neoplasms (Cancer)
05/2024 - 08/2003
22
Lymphoma (Lymphomas)
12/2022 - 08/2003
20
Multiple Myeloma
12/2023 - 02/2003
12
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 09/2004
11
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2023 - 02/2005
10
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2023 - 02/2005
9
B-Cell Lymphoma (Lymphoma, B Cell)
12/2023 - 02/2005
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2021 - 02/2012
6
Coronary Disease (Coronary Heart Disease)
04/2024 - 05/2018
6
Disease Progression
12/2023 - 09/2013
6
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2022 - 03/2007
5
Inflammation (Inflammations)
12/2023 - 01/2015
5
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020 - 02/2005
5
Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2016 - 08/2003
4
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2023 - 10/2007
4
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020 - 02/2005
4
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2019 - 09/2009
4
Residual Neoplasm
01/2016 - 04/2004
4
Leukemia
02/2012 - 03/2005
3
Plasma Cell Neoplasms
12/2022 - 01/2019
3
Bone Resorption
01/2021 - 01/2013
3
Paraproteinemias (Monoclonal Gammopathy)
09/2012 - 02/2005
3
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
08/2011 - 07/2006
3
Acute Promyelocytic Leukemia
06/2005 - 03/2004
2
Plasmacytoma
12/2023 - 12/2003
2
Autoimmune Diseases (Autoimmune Disease)
01/2023 - 08/2013
2
Rheumatoid Arthritis
01/2023 - 08/2013
2
Granuloma
01/2023 - 12/2016
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023 - 08/2013
2
Chromosome Aberrations (Chromosome Abnormalities)
01/2023 - 12/2017
2
Hematologic Neoplasms (Hematological Malignancy)
11/2022 - 01/2022
2
Dyslipidemias (Dyslipidemia)
04/2021 - 08/2018
2
Obesity
01/2021 - 11/2018
2
Blast Crisis (Blast Phase)
01/2019 - 12/2017
2
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2019 - 08/2011
2
Non-alcoholic Fatty Liver Disease
04/2017 - 01/2015
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
04/2016 - 10/2013
2
Hodgkin Disease (Hodgkin's Disease)
03/2014 - 03/2007
2
Lymphocytosis
09/2012 - 04/2005
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2011 - 02/2005
2
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
08/2011 - 03/2007
2
Pathologic Complete Response
06/2006 - 02/2006
1
Genomic Instability
04/2024
1
Mouth Neoplasms (Oral Cancer)
04/2024
1
Periodontitis
04/2024
1
Retinal Neovascularization
03/2024
Drug/Important Bio-Agent (IBA)
10
Proteins (Proteins, Gene)
FDA Link
04/2024 - 10/2004
9
Immunoglobulin M (IgM)
IBA
01/2020 - 08/2003
8
Rituximab (Mabthera)
FDA Link
01/2022 - 01/2006
7
Biomarkers (Surrogate Marker)
IBA
04/2024 - 08/2011
7
Paraproteins
IBA
12/2022 - 08/2003
7
Antigens
IBA
01/2022 - 04/2004
5
Cyclin D1
IBA
01/2023 - 01/2007
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2022 - 03/2012
5
Tyrosine Kinase Inhibitors
IBA
01/2019 - 09/2009
4
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2022 - 03/2012
4
Vincristine (Oncovin)
FDA Link
Generic
01/2022 - 03/2012
3
Messenger RNA (mRNA)
IBA
03/2024 - 10/2004
3
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
11/2023 - 04/2005
3
Immunoglobulin G (IgG)
IBA
12/2022 - 04/2005
3
Methotrexate (Mexate)
FDA Link
Generic
01/2022 - 03/2012
3
ibrutinib
IBA
01/2022 - 12/2016
3
Bortezomib (Velcade)
FDA Link
01/2022 - 10/2012
3
Dexamethasone (Maxidex)
FDA Link
Generic
01/2022 - 03/2012
3
Cytokines
IBA
01/2021 - 12/2017
3
Transcription Factors (Transcription Factor)
IBA
01/2021 - 09/2012
3
Immunoglobulins (Immunoglobulin)
IBA
10/2020 - 01/2011
3
Peroxidase (Myeloperoxidase)
IBA
01/2019 - 06/2006
2
wendan
IBA
10/2023 - 01/2023
2
Hemoglobins (Hemoglobin)
IBA
01/2023 - 03/2011
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2023 - 02/2015
2
danlou tablet
IBA
01/2023 - 02/2020
2
DAPI
IBA
11/2022 - 01/2022
2
Lenalidomide (CC 5013)
FDA Link
01/2022 - 12/2016
2
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 06/2015
2
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2022 - 03/2012
2
gualou xiebai baijiutang
IBA
04/2021 - 05/2018
2
Anaplastic Lymphoma Kinase
IBA
01/2021 - 03/2007
2
Ligands
IBA
01/2020 - 01/2013
2
Prednisone (Sone)
FDA Link
Generic
04/2018 - 01/2017
2
p38 Mitogen-Activated Protein Kinases
IBA
12/2017 - 12/2012
2
Lipids
IBA
04/2017 - 02/2016
2
Insulin (Novolin)
FDA Link
02/2016 - 10/2012
2
Formaldehyde (Formol)
FDA Link
01/2016 - 01/2009
2
Oligonucleotides
IBA
10/2015 - 10/2004
2
RNA (Ribonucleic Acid)
IBA
06/2015 - 01/2011
2
PAX5 Transcription Factor
IBA
08/2006 - 10/2004
2
Muramidase (Lysozyme)
IBA
06/2006 - 12/2003
1
Xenobiotics
IBA
04/2024
1
guizhi decoction
IBA
04/2024
1
Carrier Proteins (Binding Protein)
IBA
03/2024
Therapy/Procedure
36
Therapeutics
12/2023 - 02/2003
15
Drug Therapy (Chemotherapy)
01/2022 - 06/2005
5
Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2023 - 05/2018
4
Immunotherapy
05/2024 - 05/2005
4
Stem Cell Transplantation
01/2023 - 10/2006
2
Cell Transplantation
01/2022 - 05/2019
2
Induction Chemotherapy
01/2018 - 12/2017
2
Splenectomy
11/2012 - 04/2005
2
Combination Drug Therapy (Combination Chemotherapy)
04/2012 - 02/2006